In response to newly identified, community-based HIV epidemics, the National AETC Support Center has pulled together the following AETC Program and U...
This publication discusses the advantages and challenges of telePrEP, the use of telemedicine specifically for pre-exposure prophylaxis (PrEP), and pr...
(Available until 6/30/2023)
These 18-20 question quizzes cover essential aspects of HIV oral health and prevention, diagnosis and treatment to help end...
Quick guide for clinicians in the role of PrEP, PEP, and other HIV prevention approaches. Includes a video overview, prescribing guide, sexual history...
Below is a list of the pocket guides created by the MidAtlantic AETC:
The National HIV Curriculum (NHC) provides free, up-to-date content for healthcare professionals to learn about HIV diagnosis, treatment, and preventi...
Recorded 9/6/23
Webinar recording discusses how to identify patients at risk for HIV who may benefit from PrEP, and reviews steps for counseling and pr...
This training slide presents updated data long acting injectable (LAI) cabotegravir/rilpivirine for treatment. Differentiate monitoring st...
The following slides demonstrate how to utilize current HIV epidemiology to inform screening practices, incorporate HIV screening recommendations into...
The following slides demonstrate current trends of HIV. They describe the guidelines regarding the administration of PrEP/PEP, Rapid Start of ART in t...
This no-cost curriculum addresses how to assess, initiate, and monitor HIV PrEP.
These slides review the basic testing algorithm for HIV diagnosis in the U.S., including how to approach ambiguous test results in common clinical sce...
These slides provide an overview on barriers and challenges to HIV pre-exposure prophylaxis (PrEP) implementation in a variety of practice...
This presentation provides information on pre-exposure prophylaxis (PrEP), the challenges and novel strategies of oral pre-exposure prophy...
This presentation provides information on the current evidence supporting the use of long acting injectable cabotegravir (CAB-LA) for HIV...
This NCCC pre-exposure prophylaxis (PrEP) guide aims to provide a basic framework for clinicians and was developed based on commonly asked questions r...
This course provides an in-depth exploration of long-acting injectable antiretroviral therapies for managing HIV. Participants will gain a comprehensi...
(Recorded on 4/3/25)
Updates from the 2025 Conference on Retroviruses and Opportunistic Infections. Presenters discuss the latest research and findings...
Find upcoming training programs, in-person events, online on-demand training, and an archive of recordings.
The HIV Medication Chart is a two-page chart organized into the different categories of HIV antiretroviral medications...
There was a pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections in Boston in February. It evaluated concentrations of tenofovir (TFV) and TFV-diphosphate (DP) in genital and rectal tissue. Also in anogenital fluid samples after administration of oral tenofo...
The AETC Program's new resource combines the most up-to-date, HIV screening, prevention, and care resources in one mobile app, to provide access to essential point-of-care information and expert clinical support with just one touch.
HIV Care Tools is for busy clinicians from novice-to-expert, clinic...
The Case: The NCCC received a call from a hospital pediatrician about a baby who was born this morning to a woman with HIV. The baby was born via planned repeat Cesarean section at 39 weeks and 5 days. Records reflect that the mom is on HIV medications and has an undetectable viral load, but the cal...
